126 related articles for article (PubMed ID: 7867309)
1. Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories.
Espinel-Ingroff A; Steele-Moore L; Galgiani JN
Diagn Microbiol Infect Dis; 1994 Oct; 20(2):81-6. PubMed ID: 7867309
[TBL] [Abstract][Full Text] [Related]
2. Comparison of fluconazole minimum inhibitory concentrations in three different formulations of RPMI-1640.
Espinel-Ingroff A; Steele-Moore L
Diagn Microbiol Infect Dis; 1994 Oct; 20(2):87-91. PubMed ID: 7867310
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
To WK; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
Barchiesi F; Colombo AL; McGough DA; Rinaldi MG
J Clin Microbiol; 1994 Oct; 32(10):2494-500. PubMed ID: 7814488
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
Pfaller MA; Barry AL
Mycopathologia; 1995; 130(1):3-9. PubMed ID: 7666925
[TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
8. Determination of the minimum inhibitory concentration of Cryptococcus neoformans and Cryptococcus gattii against fluconazole by flow cytometry.
Morales BP; Junior IN; Trilles L; Bertho AL; Oliveira Rde V; Nishikawa MM; Elias Mdos S; Wanke B; Lazéra Mdos S
Med Mycol; 2014 Jan; 52(1):90-8. PubMed ID: 23808405
[TBL] [Abstract][Full Text] [Related]
9. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
10. Effect of culture media on in vitro susceptibility testing of fluconazole against some yeasts.
Sekhon AS; Garg AK; Hamir Z
Mycoses; 1991; 34(7-8):319-22. PubMed ID: 1803235
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.
Krishnarao TV; Galgiani JN
Antimicrob Agents Chemother; 1997 Sep; 41(9):1957-60. PubMed ID: 9303393
[TBL] [Abstract][Full Text] [Related]
12. Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method.
Posteraro B; Romano L; Sanguinetti M; Masucci L; Morace G; Fadda G
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):29-36. PubMed ID: 11025181
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Barry AL
J Clin Microbiol; 1994 Aug; 32(8):1992-6. PubMed ID: 7989555
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
Chen SC; O'Donnell ML; Gordon S; Gilbert GL
J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736
[TBL] [Abstract][Full Text] [Related]
15. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
16. Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.
Anaissie EJ; Paetznick VL; Ensign LG; Espinel-Ingroff A; Galgiani JN; Hitchcock CA; LaRocco M; Patterson T; Pfaller MA; Rex JH; Rinaldi MG
Antimicrob Agents Chemother; 1996 Oct; 40(10):2387-91. PubMed ID: 8891149
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
Pfaller MA; Messer SA; Hollis RJ; Jones RN
Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
[TBL] [Abstract][Full Text] [Related]
18. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
Hoban DJ; Zhanel GG; Karlowsky JA
Antimicrob Agents Chemother; 1999 Jun; 43(6):1463-4. PubMed ID: 10348771
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
Davey KG; Szekely A; Johnson EM; Warnock DW
J Antimicrob Chemother; 1998 Oct; 42(4):439-44. PubMed ID: 9818741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
